Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × Dasatinib × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Burkitt Lymphoma 4 Leukemia, Myeloid, Chronic-Phase 3 Leukemia 3 Philadelphia Chromosome 2 Neoplasms 2 Leukemia, Myeloid, Acute 2 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mastocytosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Hypereosinophilic Syndrome 1 Glioma 1 Frailty 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Cyclophosphamide 2 tazemetostat 1 romidepsin 1 pembrolizumab 1 glofitamab 1 fludarabine 1 etoposide phosphate 1 duvelisib 1 brincidofovir 1 belinostat 1 Vincristine 1 Valganciclovir 1 Therapeutics 1 Prednisone 1 Prednisolone 1 Polymerase Chain Reaction 1 Melphalan 1 Lactones 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Doxorubicin 1 Depsipeptides 1 Cytarabine 1 Cholecalciferol 1 Carmustine 1 Bendamustine Hydrochloride 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡